SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-11-002089
Filing Date
2011-03-14
Accepted
2011-03-14 07:54:18
Documents
10
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2202646z10-k.htm 10-K 1149588
2 EX-4.1 a2202646zex-4_1.htm EX-4.1 6113
3 EX-23.1.1 a2202646zex-23_1.htm EX-23.1 2632
4 EX-23.2.1 a2202646zex-23_21.htm EX-23.2.1 2838
5 EX-31.1.1 a2202646zex-31_11.htm EX-31.1.1 13093
6 EX-31.2.1 a2202646zex-31_21.htm EX-31.2.1 13458
7 EX-32.1.1 a2202646zex-32_11.htm EX-32.1.1 7016
8 G498016.JPG g498016.jpg GRAPHIC 87937
9 G22272KEI001.GIF g22272kei001.gif GRAPHIC 199233
10 G22272KEI002.GIF g22272kei002.gif GRAPHIC 123360
  Complete submission text file 0001047469-11-002089.txt   1761820
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32966 | Film No.: 11683866
SIC: 2836 Biological Products, (No Diagnostic Substances)